Short-chain fatty acid concentrations in the incidence and risk-stratification of colorectal cancer: a systematic review and meta-analysis
Open accessPublished version of a preprint
The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Abstract
Background: The beneficial role of gut microbiota and bacterial metabolites, including short-chain fatty acids (SCFAs), is well recognized, although the available literature around their role in colorectal cancer (CRC) has been inconsistent. Methods: We performed a systematic review and meta-analysis to examine the associations of fecal SCFA concentrations to the incidence and risk of CRC. Data extraction through Medline, Embase, and Web of Science was carried out from database conception to June 29, 2022. Predefined inclusion/exclusion criteria led to the selection of 17 case-control and six cross-sectional studies for quality assessment and analyses. Studies were categorized for CRC risk or incidence, and RevMan 5.4 was used to perform the meta-analyses. Standardized mean differences (SMD) with 95% confidence intervals (CI) were calculated using a random-effects model. Studies lacking quantitation were included in qualitative analyses. Results: Combined analysis of acetic, propionic, and butyric acid revealed significantly lower concentrations of these SCFAs in individuals with a high-risk of CRC (SMD = 2.02, 95% CI 0.31 to 3.74, P = 0.02). Additionally, CRC incidence was higher in individuals with lower levels of SCFAs (SMD = 0.45, 95% CI 0.19 to 0.72, P = 0.0009), compared to healthy individuals. Qualitative analyses identified 70.4% of studies reporting significantly lower concentrations of fecal acetic, propionic, butyric acid, or total SCFAs in those at higher risk of CRC, while 66.7% reported significantly lower concentrations of fecal acetic and butyric acid in CRC patients compared to healthy controls. Conclusions: Overall, lower fecal concentrations of the three major SCFAs are associated with higher risk of CRC and incidence of CRC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Clinically, measurement of fecal SCFAs or their ratios is an emerging approach for functional characterization of dysbiosis in diseases like IBD and colorectal cancer (CRC).128,129”
From Gut dysbiosis in oncology: a risk factor for immunoresistance (2026) · doi:10.1038/s41422-025-01212-6 · cites this paper as [128]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Wang, X., Wang, J. P., Rao, B., & Deng, L. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4367 · Cited by 81 · cited 1×
“Of these 28 were interventional studies, three were observational studies on serum SCFA [47–49], two studies had indistinct grouping (one case-control study with the presence of individuals with adenomatous polyps in the healthy control group [50] and one cross-sectional study with no clear definition of CRC high- and…”
BackgroundRetractedSung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699 · cited 1×
“4%) leading cause of cancer-related death [1].”
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · BMJ · doi:10.1136/bmj.n71 · Cited by 108,283
(2014) · Medical Entomology and Zoology · Cited by 17,633
Global patterns and trends in colorectal cancer incidence and mortality
Arnold, M., Sierra, M. S., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2017) · Gut · doi:10.1136/gutjnl-2015-310912 · Cited by 5,228
Dekker, E., Tanis, P. J., Vleugels, J. L. A., Kasi, P. M., & Wallace, M. B. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32319-0 · Cited by 4,974
Parada Venegas, D., De la Fuente, M. K., Landskron, G., González, M. J., Quera, R., Dijkstra, G., Harmsen, H. J. M., Faber, K. N., & Hermoso, M. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00277 · Cited by 3,820 · cited 3×
“In line with the protective role of fecal SCFAs against the development of gut diseases [15, 16], and the protective effect of dietary fibers against CRC risk and/or incidence [9–11], we determined that the combined fecal concentration of the three major SCFA molecules was significantly lower not only in CRC patients…”
BackgroundScreening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force, Bibbins-Domingo, K., Grossman, D. C., Curry, S. J., Davidson, K. W., Epling, J. W., García, F. A. R., Gillman, M. W., Harper, D. M., Kemper, A. R., et al. (2016) · JAMA · doi:10.1001/jama.2016.5989 · Cited by 2,509
Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force, Davidson, K. W., Barry, M. J., Mangione, C. M., Cabana, M., Caughey, A. B., Davis, E. M., Donahue, K. E., Doubeni, C. A., Krist, A. H., et al. (2021) · JAMA · doi:10.1001/jama.2021.6238 · Cited by 2,034
Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
Jia, W., Xie, G., & Jia, W. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.119 · Cited by 1,924
Research works printed but not linked: 1
- Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetcu R, et al. Systematic reviews of etiology and risk. In: JBI manual for evidence synthesis [Internet]. JBI; 2020. Available from: https://synthesismanual.jbi.global.
Cited by
Facchin, S., Bertin, L., Bonazzi, E., Lorenzon, G., De Barba, C., Barberio, B., Zingone, F., Maniero, D., Scarpa, M., Ruffolo, C., et al. (2024) · Life · doi:10.3390/life14050559 · Cited by 380
“A systematic review and meta-analysis by Alvandi et al., explored the role of fecal SCFAs in CRC incidence and risk stratification [149].”
BackgroundShort-chain fatty acids and insulin sensitivity: a systematic review and meta-analysis
Pham, N. H. T., Joglekar, M. V., Wong, W. K. M., Nassif, N. T., Simpson, A. M., & Hardikar, A. A. (2023) · Nutrition Reviews · doi:10.1093/nutrit/nuad042 · Cited by 162
“77 Larger clinical studies investigating the effects of these fermented beverages and food products are warranted.”
BackgroundSelf-citationRole of short‐chain fatty acids in host physiology
Liu, M., Lu, Y., Xue, G., Han, L., Jia, H., Wang, Z., Zhang, J., Liu, P., Yang, C., & Zhou, Y. (2024) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12464 · Cited by 131
Kalkan, A. E., BinMowyna, M. N., Raposo, A., Ahmad, M. F., Ahmed, F., Otayf, A. Y., Carrascosa, C., Saraiva, A., & Karav, S. (2025) · Nutrients · doi:10.3390/nu17081305 · Cited by 135
“…further human studies, the administration of 4 g of sodium butyrate daily to obese individuals diagnosed with various metabolic disorders caused enhanced innate immune memory for LPS and increased IL-6 and Pam3CSK4-induced TNF-α responses, while also reducing oxidized low-density lipoprotein…”
Dong, Y., Zhang, K., Wei, J., Ding, Y., Wang, X., Hou, H., Wu, J., Liu, T., Wang, B., & Cao, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1158200 · Cited by 107
Metadata
- Authors
- Alvandi, E., Wong, W. K. M., Joglekar, M. V., Spring, K. J., & Hardikar, A. A.
- Affiliations
- Western Sydney University (AU)
- UNSW Sydney (AU)
- Roskilde University (DK)
- Corresponding author
- Spring, Kevin J.
- Hardikar, Anandwardhan A.
- Venue
- BMC Medicine
- Published
- 2022-10-03
- Volume
- 20
- Issue
- 1
- Pages
- 323-323
- ISSN
- 1741-7015 (ISSN-L)
- PMC
- PMC9528142
- OpenAlex
- W4299878807
- Cited by
- 101
- References
- 79
- Citations by year
- 2026: 28 · 2025: 28 · 2024: 29 · 2023: 16
- FWCI
- 1.90
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- BMC Medicine (publishedVersion, cc-by)
- medRxiv (acceptedVersion)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RUCforsk (Roskilde University) (acceptedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Leona M. and Harry B. Helmsley Charitable Trust (2018 PG-T1D009)
- Danish Diabetes Academy (NNF17SA0031406])
- Novo Nordisk (NNF17SA0031406)
- Novo Nordisk Fonden (#NNF17SA0031406)
- Western Sydney University
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Keywords
- short-chain fatty acids, colorectal cancer, acetic acid, propionic acid, butyrate, gut microbiota, bacterial metabolites, colorectal cancer risk, colorectal cancer incidence, risk stratification
- MeSH terms
- Butyrates, Cross-Sectional Studies, Fatty Acids, Volatile, Feces, Humans, Colorectal Neoplasms, Incidence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Short-chain fatty acid concentrations in the incidence and risk-stratification of colorectal cancer: a systematic review and meta-analysis. https://app.cochat.ai/papers/10.1186/s12916-022-02529-4
- The paper
- Alvandi, E., Wong, W. K. M., Joglekar, M. V., Spring, K. J., & Hardikar, A. A. (2022). Short-chain fatty acid concentrations in the incidence and risk-stratification of colorectal cancer: a systematic review and meta-analysis. BMC Medicine. https://doi.org/10.1186/s12916-022-02529-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.